David Main serves as Executive at AQUINOX PHARMACEUTICALS, INC, where they oversee executive responsibilities. Since joining the company, David Main has executed 9 insider transactions totaling $207.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 5, 2017 involved selling 3,625 shares valued at $47.7K.
David Main currently holds 71,530 shares of AQUINOX PHARMACEUTICALS, INC (AQXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Main has been a net seller of AQXP stock. They have purchased $0 and sold $207.2K worth of shares.
David Main's most recent insider trade was on Jun 5, 2017, when they sold 3,625 shares at $13.16 per share.
Get notified when new Form 4 filings are submitted
| $9.60 |
| Discretionary |
| Jun 2, 2017 | AQXP | $81.5K | Sale | 6,000 | $13.59 | Discretionary |
| Jun 2, 2017 | AQXP | $57.6K | Option Exercise | 6,000 | $9.60 | Discretionary |
| Jun 1, 2017 | AQXP | $78.0K | Sale | 6,000 | $13.00 | Discretionary |
| Jun 1, 2017 | AQXP | $57.6K | Option Exercise | 6,000 | $9.60 | Discretionary |
| Mar 12, 2014 | AQXP | $104.0K | Disposition | 9,459 | $11.00 | Discretionary |
| Mar 12, 2014 | AQXP | $0 | Conversion | 71,530 | $N/A | Discretionary |
| Mar 12, 2014 | AQXP | $0 | Conversion | 71,530 | $N/A | Discretionary |